Evidence map›Paper›PMID 6190207›Full record

ArticleResearch in veterinary science1983

In vitro effects of lipopolysaccharides and mycobacterial cell wall components on swine alveolar macrophages.

B Charley, C Leclerc, E Petit, L Chedid

Abstract readComparative Study
In one paragraph

Article in Research in veterinary science, 1983. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Effects of immunopotentiating agents on alveolar macrophage properties.Comparative immunology, microbiology and infectious diseases · 1986
    Review
  7. [Swine alveolar macrophages: a review].Comparative immunology, microbiology and infectious diseases · 1985
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

B Charley
C Leclerc
E Petit
L Chedid
Institut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The possible activation of swine alveolar macrophages (AM) by lipopolysaccharides (LPS) and mycobacterial cell wall components such as muramyl dipeptide (MDP) and interphase material (IPM) was investigated. Swine AM were harvested by post mortem lung washings and the following functions were assayed: adherence and spreading in cultures; phagocytosis of 51Cr-labelled chicken red cells; cytostatic activity against xenogeneic tumour cells (P815 mastocytoma cells); monokine synthesis; interferon and LAF (lymphocyte activating factor or interleukin-1). Incubation of swine AM with either MDP, LPS or IPM (0.1 micrograms to 100 micrograms/ml) for 24 hours did not affect the cell viability but increased their adherence and spreading slightly. Phagocytosis was not markedly modified. Under the same experimental conditions, the unstimulated AM cultures exhibited a strong cytostatic activity which was not modified by these components. No interferon synthesis could be observed in the normal or stimulated AM cultures. In contrast, LAF activity was consistently increased after 48 hours of incubation with LPS, whereas MDP produced this effect only in some experiments.

Indexed as

Acetylmuramyl-Alanyl-IsoglutamineAnimalsCell WallInterferonsInterleukin-1In Vitro TechniquesLipopolysaccharidesLymphokinesMacrophage-Activating FactorsMacrophage ActivationMacrophagesMaleMast-Cell SarcomaMiceMice, Inbred BALB CMycobacteriumAcetylmuramyl-Alanyl-IsoglutamineInterferonsInterleukin-1LipopolysaccharidesLymphokinesMacrophage-Activating Factors

Identifiers

PMID6190207
PMCPMC7125692
OpenAlexW2405206470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.